Carmel Pharma

Columbus, United States Founded: 1994 • Age: 32 yrs Acquired By Becton Dickinson
Closed-system transfer devices are produced for safe hazardous drug handling.

About Carmel Pharma

Carmel Pharma is a Healthcare company based in Columbus (United States) founded in 1994, and was acquired by Becton Dickinson in July 2011. Closed-system transfer devices are produced for safe hazardous drug handling. Carmel Pharma has raised $2.56 million across 2 funding rounds from investors including BD and 3i Group. The company was acqui-hired. Its focus areas include Life Sciences, Hospital Equipment, Occupational Hazard Prevention and CSTD Devices. Its legal entity is Carmel Pharma Inc. Its competitors include ICU Medical, Equashield and Corvida Medical; 1 of its 3 listed competitors has raised funding.

Company details

Founded in 1994 and based in Columbus, United States, Carmel Pharma operates in the medical device sector, focusing on the PhaSeal System, an FDA-approved closed-system transfer device. This system is utilized by healthcare providers in hospitals for managing hazardous drugs, with implementations across cancer centers, oncology practices, and specialty pharmacies in the United States, Europe, and Asia. Acquisition by Becton-Dickinson occurred in 2011.

Key Metrics

Funding Insights of Carmel Pharma

Carmel Pharma has successfully raised a total of $2.56M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.56M
  • Total Rounds 2
  • First Round $2.56M

    (Jan 1999)

  • Investors Count 1

All 2 funding rounds of Carmel Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2005Private Equity Round–3i Group
–
Jan 1999$2.56MSeries A––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Carmel Pharma

Carmel Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BD and 3i Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on mid-market businesses
19453i.comLondon, United Kingdom
BD is recognized for providing innovative medical technology solutions.
1897bd.comFranklin Lakes, United States
Premium access

Investor details for Carmel Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Carmel Pharma

4 dated milestones of Carmel Pharma across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Carmel Pharma is founded.
  2. Funding First funding round of $2.6M.
  3. Funding Latest funding round, Private Equity Round,.
  4. Exit Acquired by Becton Dickinson.

Competitors of Carmel Pharma

Carmel Pharma has 3 listed competitors in our database, 1 of them funded. They include ICU Medical, Equashield and Corvida Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
icumed.com1984San Clemente, United States6
Drug and Infusion delivery devices
equashield.com2009New York, United States$300M59
Closed-system transfer devices for hazardous drug handling are developed.
corvidamedical.com2008Coralville, United States5
Closed system transfer device for safe administration of hazardous drugs
Premium access

Detailed competitors of Carmel Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as Carmel Pharma (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 3.07 B10,600
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Carmel Pharma

Premium access

Complete news archive for Carmel Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Carmel Pharma

Carmel Pharma was founded in 1994 and raised its 1st funding round 5 years after it was founded.

Carmel Pharma is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.

Carmel Pharma is a funded company, having raised a total of $2.56M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.56M, raised on Jan 1999.

Founded in 1994 and based in Columbus, United States, Carmel Pharma operates in the medical device sector, focusing on the PhaSeal System, an FDA-approved closed-system transfer device. This system is utilized by healthcare providers in hospitals for managing hazardous drugs, with implementations across cancer centers, oncology practices, and specialty pharmacies in the United States, Europe, and Asia. Acquisition by Becton-Dickinson occurred in 2011.

Carmel Pharma's top competitors include Equashield, ICU Medical and Corvida Medical.

Carmel Pharma has 2 investors. Key investors include BD, and 3i Group.

Carmel Pharma operates through Carmel Pharma Inc.

Yes. Carmel Pharma was acquired by Becton Dickinson in July 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available